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ABSTRACT
The purpose of my research is to determine if the substitution of selenium for sulfur will

cause rate acceleration of the thiol-disulfide exchange reaction in the C-terminal redox center of
Plasmodium falciparum thioredoxin reductase (PfTR) in a position specific manner. P.
falciparum is the protist that causes most serious form of malaria and is responsible for the
majority of malaria related deaths. While mammalian thioredoxin reductase (mTR) contains
selenium in its C-terminal redox center, which accelerates the rate of reaction, PfTR functions in
the absence of selenium. The results of my studies show that the introduction of selenium via
selenocysteine to the C-terminal redox center of PfTR impacts the rate of this reaction positively
when substituted at Cys540 and negatively at Cys535. This data can be explained mechanistically
by the use of a disulfide electrophilic activation mechanism by PfTR. Specifically, the disulfide
bond between Cys540 and Cys535 in the C-terminal redox center of PfTR is primed for attack by
the thiolate of Cys93 of the N-terminal redox center because of a hydrogen bonding interaction
between Cys535 and an adjacent histidine residue. This interaction polarizes the Cys540–Cys535
disulfide, making the sulfur atom of Cys540 highly electrophilic. The differential effects on rate
caused by selenium substitution of each of the two sulfur atoms of the C-terminal disulfide
represents a “seleno effect”, similar to the observed “thio effect” in phosphodiesterases when
sulfur substitutes for oxygen in non-bridging oxygen atoms of phosphodiesters. Thioredoxin
reductase is essential in all organisms and its loss of function is deadly for the host. Due to the
differences in structure between PfTR and mTR, the mechanism proposed represents a potential
drug target in the fight against malaria.
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The Thioredox System
The thioredoxin system is comprised of the small protein thioredoxin (Trx), thioredoxin
reductase (TR), and NADPH. The components and function of this system is described in the
following sections.
Thioredoxin.
Thioredoxin (Trx) is a class of small disulfide-containing oxidoreductases that is
ubiquitous from archaea to humans.1 The TRX gene encodes the human variant of the protein,
and a loss of function mutation of this gene is lethal at the four cell stage of development.2, 3 Trx
is a 12KD highly conserved protein and has multiple functions including 1) facilitating thioldisulfide exchange between itself and a target protein 2) donating electrons to target proteins and
3) quenching reactive oxygen species (ROS) as an antioxidant.4 Its redox exchange capability is
essential to many different processes throughout all cells and new systems are continually being
discovered in which Trx plays a role. It has been found to be involved in regulation of metabolic
pathways via redox signaling as well as through its control of oxidative stress.5, 6 The defining
trait of Trx is the presence of two vicinal cysteine residues within its active site in a –Cys-GlyPro-Cys- amino acid motif. These cysteines exist as either the active, reduced form (Trx(SH)₂)
or the inactive, oxidized, disulfide form (TrxS₂). When reduced Trx(SH)₂ reacts with a target
protein it loses two hydrogens and becomes oxidized, subsequently reducing the target protein.7
Trx is kept in the reduced state by the flavoenzyme thioredoxin reductase, which then in turn
utilizes NADPH to maintain its reduced state. 4
Targets of Trx. One function of Trx is to reduce disulfide bonds on target proteins through thioldisulfide exchange. This involves attack by one of the reduced sulfur groups within the Trx
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active site on the target protein disulfide. This forms a mixed disulfide between Trx and its target
sulfur, with the other sulfur that was previously part of the target disulfide becoming a thiolate.
The remaining thiolate group on the Trx protein then attacks this mixed disulfide, forming a new
disulfide between the two cysteine residues of Trx and releasing the newly reduced target
protein, as is illustrated in Figure 1.8 This process of thiol-disulfide exchange is repeated when
Trx reductase reduces the oxidized Trx, which then allows the Trxtarget cycle to continue.
Targets of Trx that undergo this exchange include insulin, choriogonadotropins,
coagulation factors, and glucocorticoid receptor, among many others.9 While the function of Trx
in many cases is simply to keep intracellular protein disulfides reduced it can also serve as a
regulatory protein.10 In plants it interacts with ferredoxin to regulate chloroplast photosynthetic
enzymes, while in mammals it is used for the redox regulation of multiple transcription factors,
including AP-1 and NFκB, to allow for communication between the nucleus and cytoplasm.11, 12
Through a different regulatory strategy reduced Trx can also interact with ASK1 in mammals to
prevent downstream signaling of apoptosis.13
Trx also has a secondary function as hydride donor, which is analogous to the function of
NADH or NADPH. It is used in conjunction with peroxidases called peroxiredoxins to turn ROS
such as H₂O₂ into water or alcohols.14 Trx was originally purified from Escherichia coli, where
it was isolated as a hydrogen donor for ribonucleotide reductase, an essential enzyme that
converts ribonucleotides to deoxyribonucleotides.15 This interaction dictates that all organisms
that have DNA must also have Trx, and partially accounts for the essential nature and ubiquity of
Trx throughout evolutionary history. Other utilizations of Trx as a hydride donor include protein
repair by methionine sulfoxide reduction and assimilation of sulfur by sulfate to sulfite reduction
in bacteria and yeast.16
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In addition to being a substrate for peroxiredoxins and transitively acting as an

antioxidant through them, Trx can also quench ROS and act as a direct antioxidant. The reduced
cysteine residues of the active site can donate electrons to ROS reducing them. The active site
cysteines become oxidized to sulfenic acid or sulfinic acid as a result. This reaction is much
slower than peroxiredoxin activity and as such its antioxidant capability is less. However,
peroxidases can only act on hydrogen peroxide while Trx can quench superoxide and hydroxyl
radical as well as hydrogen peroxide. 17
Thioredoxin Reductase.
Thioredoxin reductases (TR) are members of the flavoprotein family of pyridine
nucleotide disulfide oxidoreductases. Other enzymes in this class include lipoamide
dehydrogenase, glutathione reductase, and NADH peroxidase. TR catalyzes the NADPH
dependent reduction of Trx and other substrates by transferring electrons through a series of
redox centers. All organisms express some form of TR and they are categorized into two major
classes; a low-molecular weight (Mr) class of 35 KDa that includes bacteria, archaea, and some
eukaryotes such as plants, and a high-Mr class of 55 KDa found in many animals, including all
mammals. Both classes exist as homodimers, with each monomer possessing a prosthetic flavin
(FAD) redox domain as well as one or two disulfide redox centers, depending on the class. The
reaction to reduce thioredoxin or another substrate begins with NADH binding to the enzyme
and reducing the flavin group to FADH₂. This initiates a chain of thiol-disulfide redox reactions
within the enzyme, ending with the reduction of the substrate. Within the classes of TR enzymes
there are subdivisions, and while all of them reduce Trx there are slight variations in the
mechanisms which allow for some TR enzymes to have a wider range of substrates than others.
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High Mr Thioredoxin Reductase. High Mr TRs contain a flavin prosthetic group redox center as
well as two disulfide redox centers, one N-terminal and one C-terminal. The N-terminal redox
center has a conserved sequence of -Cys-Val-Asn-Val-Gly-Cys- adjacent to the flavin domain.
This motif is identical to the redox center of the related enzyme glutathione reductase, which
uses the redox center to directly reduce the oxidized form of the glutathione tripeptide. In TR the
N-terminal redox center reduces the C-terminal redox center through thiol-disulfide exchange,
which then subsequently reduces Trx. This is illustrated in Figure 2. The C-terminal center
varies between species and allows for further classification of the TR enzyme into selenocysteine
(Sec) containing and cysteine (Cys) only redox centers. High Mr TR is highly divergent from
low Mr TR, which does not contain a C-terminal redox center, and the sequence identity between
the two was found to be only 31%, while the sequence identity between high Mr TR and
glutathione reductase is 44%. 18
Sec containing High Mr TR. In mammalian variants of the TR enzyme (mTR) the C-terminal
redox center contains the rare amino acid selenocysteine (Sec). This redox active site has a
tetrapeptide sequence of –Gly-Cys-Sec-Gly- and is conserved among all isozymes of mTR. In
the amino acid selenocysteine, selenium replaces the sulfur atom of a cysteine residue and
participates in redox reactions through thiol-disulfide like exchange. Mammalian TR enzymes
with this C-terminal redox sequence are designated Type Ia. In humans there are three isozymes
of mTR; cytosolic mTR, mitochondrial mTR, and testes-specific mTR. Cytosolic mTR is
structurally unique in comparison to all other high Mr TR enzymes and within the literature it is
categorized as TR1. Mitochondrial mTR is referred to as TR3 and most other high Mr TRs are
referred to as TR3-like for their relative similarity to this variant. The reason for this distinction
is that TR1 contains a “guiding bar” (amino acids 407-422) within its structure that prevents the
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C-terminal redox center from moving away from the N-terminal redox center and exposing it.19
This is important because for enzymes that lack this guiding bar, such as TR3, the N-terminal
redox center is exposed and can interact with substrates directly, bypassing the C-terminal redox
center. This mechanism is analogous to the mechanism of substrate reduction by glutathione
reductase. It has been shown that TR3 and TR3-like enzymes can reduce a wide range of
substrates including 5,5’-dithiobis(2-nitrobenzoic acid) (DTNB), lipoic acid, and selenocystine
without the presence of the active Sec residue in their C-terminal redox center by interacting
with the N-terminal redox center directly. However, when a mutation is made to a TR1 enzyme
to eliminate this Sec its catalytic activity is decreased over 100 fold for all of these substrates due
its inability to apply the alternative reduction pathway through the N-terminal redox center. 20
Why Selenocysteine? Selenium is located directly below sulfur on the periodic table, and as such
has many of the same chemical properties. However, because selenium is a much larger element
with a bigger electron cloud it can both accept and donate electrons better than sulfur. While
sulfur is a good electron donor, or nucleophile, it has less ability to accept electrons in
comparison to selenium. Selenium can be described as a Janus-faced element, meaning that it
can act as both as a very good nucleophile and a good electrophile, especially as part of a
selenosulfide bond or as an Se-oxide. This allows selenium to perform chemistry in ways that
sulfur cannot, and in the case of TR allows the selenium residue in the active site to attack one of
the sulfurs of the Trx disulfide much faster and more reliably than a simple cysteine residue
could. It has been shown previously that selenium not only acts as a nucleophile when it attacks
the Trx disulfide, but it also acts as an electrophile during the thiol-disulfide exchange between
the N-terminal and C-terminal redox centers.20 This overall chemical advantage of selenium over
sulfur is necessary in mTR to turn over Trx quickly and efficiently.21 Selenium also has a
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chemical advantage over sulfur in its ability to resist inactivation by oxidation. When the sulfur
atom in a cysteine molecule is exposed to ROS it can become permanently over-oxidized to the
sulfinic acid form. This causes the cysteine residue loses its chemical reactivity and ability to
perform redox reactions.22 However, the Janus faced nature of selenium prevents irreversible
oxidation of selenocysteine, which is important because Trx is essential in eliminating ROS.23 If
TR became inactivated due to ROS it would not be able to turn over inactive Trx in the event of
a sudden influx of ROS, which would defeat the antioxidant capabilities of the thioredoxin
system.
Cysteine only enzymes. High Mr TR enzymes have been discovered in Drosophila melanogaster
(DmTR) and Plasmodium falciparum (PfTR) that do not contain any selenocysteine in their
respective amino acid sequences. They instead utilize two cysteine residues within their Cterminal redox centers. The structure of these redox centers differs between the two organisms,
with D. melanogaster having a sequence of –Ser-Cys-Cys-Ser- and P. falciparum having one of
–Gly-Cys-Gly-Gly-Gly-Lys-Cys-Gly. When oxidized the DmTR C-terminal redox center forms
a ring of eight atoms, which is analogous to the structure of the oxidized C-terminal redox center
of the mammalian variant of TR. DmTR is designated a Type Ib TR for this reason.24
Alternately, the oxidized PfTR redox center forms a twenty membered ring, which among TR
enzymes has only been discovered in apicomplexan TRs and as such is given its own category as
a Type II TR.25 Both of these are also classified as TR3-like enzymes as both their N-terminal
and C-terminal redox centers can reduce substrates. Drosophila melanogaster actually lacks
glutathione reductase so glutathione is a substrate for DmTR and is reduced within the Nterminal redox center, which is a reaction unique to insects. 26
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Low Mr TR. While low Mr TRs and high Mr TRs are homologous, the two classes are
structurally and mechanistically dissimilar. The Escherichia coli variant is the most widely
studied low Mr TR so knowledge of the class is largely based on this specific enzyme. As
mentioned previously, the low Mr TR class lacks the C-terminal redox center found in high Mr
TRs and instead has a single disulfide redox center that directly reduces Trx via thiol-disulfide
exchange. The mechanism of reduction begins with the binding of NADPH to its binding site.
This induces a rotation within the enzymes structure to bring the NADPH adjacent to the flavin
domain, which allows for rapid hydride transfer. At the same time the previously reduced
nascent thiol redox center moves away from the flavin domain and rotates toward the surface of
the protein to undergo thiol-disulfide exchange with the waiting Trx protein substrate. When
NADP+ is released the reverse rotation brings the newly oxidized thiol redox center adjacent to
the reduced flavin domain to be reduced. This process of rotation differs from the relatively static
mechanism of the high Mr TR.27
High Mr TR Mechanism.
The focus of this thesis is to solve the mechanics of electron flow between the N-terminal
and C-terminal redox centers of PfTR, namely which cysteine of the C-terminal redox center
undergoes attack by the N-terminal redox center and why this reaction is favorable. In order to
solve this problem it is necessary to have an understanding of these mechanics within other high
Mr TR variants. The sequence of the C-terminal redox center is a significant difference between
the various types of high Mr TR enzymes and the reduction of the C-terminal center by the Nterminal center is the focus of my studies. The mechanism of this reduction step can be studied
and determined through enzyme assays, which is the approach I have taken here. 28 Below is a
description of the flow of electrons from NADPH to the substrate catalyzed by TR.
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For all high Mr TRs the state of the enzyme immediately after reduction of a substrate

exists as the flavin domain oxidized and hydrogen bonded to the N-terminal redox center, which
is reduced. At this point the C-terminal redox center is an oxidized disulfide/selenylsulfide. The
N-terminal center then undergoes thiol disulfide exchange with the C-terminal center, reducing
it. NADPH then binds and the flavin is reduced to FADH₂. This immediately undergoes redox
exchange with the N-terminal center, returning it to a reduced state. At this stage both redox
centers are reduced. Trx(S₂) then binds to the C-terminal domain and undergoes thiol disulfide
exchange. It leaves as Trx(SH)₂ and the TR enzyme is returned to its original oxidation state. It
is important to note that the structure of TR is that of a homodimer, with the redox motifs of each
monomer oriented as follows; C-terminal redox center, NADPH binding domain, flavin domain,
and then N-terminal redox center. The two monomers are linked “head to tail” so that the Nterminal redox center of one monomer is reducing the C-terminal redox center of the opposite
monomer. The transfer of electrons between these monomers is the process that this thesis is
concerned with.
The mechanism of thiol/disulfide exchange of the C-terminal redox center of mTR. As previously
stated, mTR enzymes have a C-terminal redox center sequence of –Gly-Cys495-Sec496-Gly-OH.29
In the oxidized state (with a selenosulfide bond), this tetrapeptide forms an eight membered ring.
This selenosulfide undergoes a thiol-disulfide exchange reaction with the N-terminal redox
center of the opposite monomer of the homodimer. The N-terminal center is composed of an
interchange Cys residue (CysIC) and a charge transfer Cys residue (CysCT) that form a disulfide
bond in the oxidized state. This N-terminal disulfide is reduced by the flavin group. This
reduction results in a nucleophilic CysIC that attacks the electrophilic Sec residue of the vicinal
selenosulfide bond and forms a new mixed selenosulfide bond connecting the two redox centers.
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The thiolate of the CysCT then attacks CysIC, reforming the oxidized N-terminal disulfide bond
and leaving the C-terminal redox center fully reduced as a thiol and a selenolate. This Sec
residue then attacks the vicinal disulfide of Trx(S₂), acting this time as the nucleophile in the
thiol-disulfide-like exchange. This leaves the C-terminal center oxidized and Trx reduced.28 The
utilization of the unique chemical capabilities of selenium in this mechanism allow for rapid
intramolecular electron exchange and resistance to inactivation by oxidation.
DmTR C-terminal Redox Mechanism. The C-terminal redox center of DmTR is a tetrapeptide
with an active site sequence of –Ser-Cys489-Cys490-Ser-COO⁻. When in the oxidized disulfide
state this motif forms an eight-membered ring similar to the one formed in this complex within
mTR. However, because this redox center lacks Sec it must somehow mimic the properties of
selenium within one of the Cys residues to allow rapid electron transfer to occur. The enzyme
does this by positioning a positively charged histidine (HisH+) residue adjacent to the Cys489 of
the disulfide. The positive charge of the His induces a negative charge on the Cys489 sulfur,
which creates a dipole within the disulfide and gives the sulfur of Cys490 a partial positive
charge. By doing this the Cys490 is made electrophilic and can undergo attack by the CysIC
residue of the N-terminal redox center. In the literature this mechanism has been deemed
“electrophilic activation”.30 After the C-terminal redox center has been reduced it can undergo
thiol-disulfide exchange with Trx(S2) by attacking the disulfide bond of Trx(S2) with Cys490.
This reaction is made favorable by the presence a Ser residue adjacent to Cys490 that stabilizes its
sulfur as a thiolate through hydrogen bonding after reduction. A thiolate is a much better
nucleophile than the thiol group that would form in the absence of the Ser residue and allows the
C-terminal redox center to reduce the substrate at a more rapid rate.29 Through these mechanisms
Cys 490 is made chemically similar to Sec during the redox reactions involving the C-terminal
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center, allowing the enzyme to perform the same chemistry as mTR without the need for
selenium.
PfTR Proposed Mechanism. The C-terminal redox center of PfTR is structurally very different
from the other two variants discussed, but it is hypothesized in this thesis that the redox
mechanisms are similar. The active site sequence of this enzyme is –Gly-Cys534-Gly-Gly-GlyLys-Cys541-Gly-COO-, which forms a twenty-membered ring in the oxidized state. The presence
of the disulfide introduces this motif to undergo a transition from and intrinsically disordered
state to a β-turn-β motif, which is stabilized by hydrogen bonding between the amino acids of the
ring. Deletion or substitution of any of the amino acids of the sequence decreases the catalytic
activity of the enzyme.25 The unique structure of this C-terminal redox center allows this enzyme
to specifically reduce its native substrate, the Plasmodium falciparum variant of Trx (PfTrx).31
Although this ring is much larger than those of DmTR and mTR, I propose that it undergoes
electrophilic activation in a way similar to the mechanism of DmTR. Like DmTR, a positively
charged histidine residue (His509) is located adjacent to the C-terminal redox center of PfTR. I
hypothesize that this residue hydrogen bonds with the more N-terminal cysteine residue of the
redox center disulfide, Cys535, to induce a positive charge on more C-terminal cysteine, Cys540,
priming it to be attacked by the N-terminal redox center. This is illustrated in Figure 7. These
assigned roles for the cysteine residues are based on the mechanisms of mTR and DmTR.28, 32
Inhibition of Hydrogen Bonding
Thio effect. The substitution of sulfur in place of phosphate bound oxygen is a tool mainly used
to determine the mechanisms of RNA phosphodiester bond cleavage by ribozymes and DNA
phosphodiester cleavage by phosphodiesterases like RNase A.33, 34 As sulfur is directly below
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oxygen on the periodic table it less electronegative, larger, more readily polarizable, and has a
lower pKa. When oxygen is replaced with sulfur within a phosphate group many properties of
that group can be altered, including its hydrogen bonding capabilities, the geometry of the
phosphorane intermediate, its leaving group property, and its affinity to metal ions.35 The
substitution of sulfur at the different oxygen positions within a phosphate group will typically
decrease the Kcat of the enzyme being studied and allow for insights into the mechanism of
catalysis. This change is expressed as a ratio of kO/kS, where O is the native oxygen substrate and
S is the sulfur analog, and this ratio is called the “thio effect”.36 A common example of this is the
substitution of sulfur for oxygen at a non-bridging oxygen atom of a phosphate group. Typically
the phosphorous atom is activated for nucleophilic attack from an enzyme by hydrogen bonding
between the non-bridging oxygen and a positively charged hydrogen bond donor. The lower
basicity of sulfur in comparison to oxygen results in a lower ability of the sulfur atom to engage
in hydrogen bonding or to formally accept a proton. This results in less activation of the
phosphorous atom of a phosphorothioate compared to a phosphorous atom of a phosphate,
resulting in a slower rate of reaction.37
Seleno Effect. This concept can be extended to the replacement of a native sulfur atom in a
disulfide bond with the element below it on the periodic table, selenium. The differences
between Se and S can be used to explore mechanisms in the same way that O to S substitution
can. This concept has been used to account for differences in hydrogen bonding between Cys and
Sec residues within the active sites of enzymes due to the lower pKa of Sec compared to Cys.
Within the context of TR, the Cys residue of the C-terminal redox center that is not attacked
during redox exchange undergoes hydrogen bonding with an adjacent histidine residue, which in
the case of DmTR and likely PfTR induces a dipole in the disulfide and allows the Cys to

	
  

14

become protonated easily upon reduction. This same mechanism was proposed for the PfTR
mechanism.25 When this activating C-terminal Cys in DmTR was replaced with Sec the rate of
the thiol disulfide exchange reaction was decreased by 10-fold.30 The substitution of Se in place
of S in the redox center disulfide lowered the pKa of the residue and in doing so decreased the
effect of hydrogen bonding by an adjacent positively charged histidine residue, and resulted in a
less polarized selenosulfide bond. This made the disulfide less likely to undergo attack by the Nterminal redox center and lowered the overall rate of thiol disulfide exchange. It is hypothesized
that a similar substitution of the activating CysSec in PfTR will result in a comparable
decrease in activity due to this seleno effect. The mechanism by which this occurs is shown in
Figure 8.
The purpose of this project is to determine the mechanism of redox exchange between the
N-terminal and C-terminal redox centers of PfTR. In order to isolate which cysteine residue of
the C-terminal redox center is being attacked, as well as identify if hydrogen bonding is
occurring to polarize the disulfide, the seleno effect was utilized through substitution of the
cysteine residues with selenocysteine. It is hypothesized that an electrophilic activation
mechanism exists in the C-terminal redox center of PfTR through hydrogen bonding between
His509 and Cys535, which induces a partial positive charge on Cys540 and makes it more prone to
attack by the N-terminal redox center.

	
  

15

MATERIALS AND METHODS
Materials. Vent DNA polymerase, NdeI, SapI, T4 DNA ligase, E. coli ER2566 competent cells,
and chitin-agarose beads were purchased from New England Biolabs (Ipswich, MA). GSH sepharose 4 Fast Flow, benzamidine sepharose, and 2′-4′-ADP-sepharose resins were obtained
from GE Healthcare (Waukesha, WI). Solvents for peptide synthesis were purchased from EMD
Biosciences (San Diego, CA). Fmoc-amino acids were purchased from Synpep Corp (Dublin,
CA). Fmoc-Sec-Xanthene was obtained as a gift from Dr. Steven Flemer38. Resins for solidphase synthesis were purchased from Applied Biosystems (Foster City, CA). All other chemicals
were purchased from either Sigma-Aldrich (Milwaukee, WI) or Fisher Scientific (Pittsburgh,
PA). The HPLC system was from Shimadzu with a Symmetry® C18 -5 µm column from Waters
(4.6 x 150mm). A Voyager-DETM PRO Workstation (Applied Biosystems) was used for mass
spectral analysis of peptide samples. All enzyme kinetic assays were performed on a Cary50
UV-vis spectrophotometer (Cary, Walnut Creek, CA) and were conducted at room temperature.
Production and Purification of Semisynthetic PfTR mutants and PfTRΔ7. The production of
enzymes A and B of Table 2, as well as the PfTRΔ7 that was used in the peptide assays, was
achieved through intein-mediated peptide ligation39. First a truncated PfTR construct, PfTRΔ7,
was formed by through PCR amplification of the full length wild type PfTR DNA template. The
upstream primer that introduced a NdeI restriction site (sequence: 5'ACAGACATATGGGATCCTGC-AAA-3′) and a downstream primer which introduced a seven
amino acid deletion, the insertion of a Cys residue, and a SapI endonuclease restriction site
(sequence: 5′-ACAGCCGCTCTTCAGCAACCACCTTT-3′) were used. PCR was done on an
Eppendorf Mastercycler using Vent DNA polymerase. The amplified sequence was then digested
with NdeI and SapI and shuttled into the pTYB1 expression vector from New England Biolabs.
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Ligation of the product was then conducted using T4 DNA ligase. The resulting plasmid was
used to produce the PfTRΔ7-intein-chitin binding domain fusion protein in E. coli ER2566 cells
with Sce VAM intein (both provided by New England Biolabs).
These cells were grown in Terrific broth medium with niacinamide, riboflavin, and
pyridoxine supplementation (20 mg/L each). The cell culture, containing 0.2 µg/mL ampicillin,
was grown at 37 °C until the OD600 reached∼0.6. The cells were then cooled to 20 °C, and
IPTG was added to induce expression to a final concentration of 0.5 mM, with subsequent
incubation done at 20 °C overnight on a shaker. The cells were harvested by centrifugation (9000
rpm in a Beckman J2-21 preparatory centrifuge for 10 min at 4 °C) following overnight
incubation. The harvested bacterial cell pellet was normalized in chitin buffer A [50 mM MOPS
and 150 mM NaCl (pH 7.0)] followed by cell lysis via pulse sonication. The lysed slurry was
then pelleted via centrifugation (12000 rpm in a Beckman J2-21 preparatory centrifuge for 1 h at
4 °C), and the cleared lysate was loaded onto a chitin−agarose column pre-equilibrated with
chitin buffer A. The intein-chitin binding domain fused to PfTR allowed it to bind to the resin
with high specificity. The loaded PfTR protein was further washed with 0.5 L of chitin buffer A
followed by additional washing with 0.5 L of high-salt chitin buffer B [50 mM MOPS and 500
mM NaCl (pH 7.0)]. Chitin buffer B was then added to the resin containing the bound protein to
convert it to slurry, which was then transferred to two 50 mL conical tubes.
The semisynthetic PfTR enzymes (A and B of Table 2) were produced via ligation of
desired synthetic peptides to the truncated PfTRΔ7 containing a C-terminal thioester reactive
group. Proteins containing a C-termimal thioester can be ligated to peptides that have an Nterminal Cys residue to form an amide bond 39. Simultaneous cleavage of the fusion protein and
ligation with synthetic peptide were achieved by addition of a cleavage cocktail consisting of 120
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mM N-methyl mercaptoacetamide (NMA) and the desired synthetic peptide in chitin buffer B
(pH 8.0−8.5). The cleavage and ligation reaction was done at room temperature overnight with
constant shaking. Following overnight incubation, the resin/chitin slurry was poured back onto
the column and the liberated semisynthetic enzyme was eluted via gravity flow and washing with
chitin buffer B. The semisynthetic enzyme was concentrated and buffer exchanged with buffer C
[10mM NaCl, 10mMTris-EDTA, and 20 mM βME (pH 8.0)] via ultrafiltration (Amicon Ultracel
30 kDa cut off filters). It was then loaded by gravity onto a pre-equilibrated 2′,4′-ADP-sepharose
column (20 mL). After the sample had been extensively washed with buffer C, the semisynthetic
PfTR enzyme was eluted off the 2′,4′-ADP-sepharose column with high-salt buffer [10 mM TrisEDTA, 1 M NaCl, and 20 mM βME (pH 8.0)]. The fractions containing PfTR were confirmed
by spectrophotometry and SDS−PAGE, pooled, and then buffer exchanged via ultrafiltration
with storage buffer [50 mM potassium phosphate, 500 mM NaCl, and 1 mM EDTA (pH 8.0)].
The concentration of each PfTR semisynthetic enzyme was determined through spectral analysis
via the absorbance maximum of the flavin at 460 nm (ε = 22.6 mM−1 cm−1, representing the
dimer).
The truncated enzyme (PfTRΔ7) was produced for use in kinetic peptide substrate assays
by cleaving the PfTRΔ7−intein fusion protein in the presence of NMA, without peptide present.
After cleavage from the chitin−agarose column, pooled fractions of PfTRΔ7 were concentrated
by ultrafiltration and loaded onto a Sephacryl-S200 column that had been pre-equilibrated with
50mM potassium phosphate, 500 mM NaCl, and 1 mM EDTA (pH 8.0). TR-positive fractions
eluted off the column and were then pooled and concentrated using the methods above.
Syntheses of Cysteine Peptides. All peptides were synthesized with a Burrell Model 75 wristaction shaker (Pittsburgh, PA). Peptides were synthesized on a 0.3 mmole scale using 2-
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cholorotridylchloride resin (1.33 mmol/g loading) at 3 eq. excess. For each peptide synthesis the
resin was first swelled in dichloromethane (DCM) for 30 min. and then the first amino acid was
coupled using 1.1 eq. Fmoc-AA-OH dissolved in 5 mL of a 2.22% N-methylmorpholoine
(NMM)/ 97.7% DCM (0.2 M NMM) solution and shaken for one hour. The resin was then
washed four times using DCM and capped with 10 mL of 8:1:1-DCM:Methanol:NMM and
shaken for fifteen minutes. Following this the resin was washed 4X with DCM and 4X with
dimethylformamide (DMF). Deprotection of the N-Fmoc protecting group was carried out using
two 10-min agitations with a solution of 20% piperidine/ 80% DMF. Success of all deprotections
and amino acid couplings were monitored qualitatively using a ninhydrin test40. Elongation of
the peptides used standard Fmoc SPPS chemistry with 2 eq. (equivalents relative to peptide
synthesis scale in mmoles) HATU and 2 eq. Fmoc-AA-OH in 5 mL of a 4.40% NMM/ 95.6%
DMF (0.5 M NMM) solution, shaken for one hour41. Following a final deprotection and 4X wash
with DCM these peptides were cleaved from the resin with a cocktail consisting of 96:2:2
trifluoroacetic acid(TFA):triisoproprylsilane(TIS):H2O for 2 hr. The solution was blown into a
conical using nitrogen gas and the resin was washed four times using DCM. The cleavage
cocktails were dripped into cold, anhydrous diethyl ether to precipitate the peptide and then
pelleted by centrifugation. The pellet was allowed to dry and then redissolved in 1 mL of the
96:2:2 TFA:TIS:H2O cocktail, dripped into anhydrous diethyl ether and centrifuged to pellet
(2X). The peptide was then dissolved in a minimal amount of a water/acetonitrile mixture and
lyophilized. This process is illustrated in Figure 3.
Syntheses of Selenocysteine Peptides. The amino acid Fmoc-Sec-xanthene was used as the
selenocysteine residue for the two Sec peptides. The resin and procedure for these peptides was
the same as described previously, with one exception. When coupling Fmoc-Sec-Xan and all

	
  

19

other amino acids following it in the synthesis the conditions were 2 eq. Fmoc-AA-OH and 4 eq.
HOAT dissolved in 5 mL of 1.88% diisopropylcarbodiimide (DIC)/98.1% DMF (94 uL/4.906
mL) shaken for three hours for Sec or one hour for any other amino acid. The cleavage and
swelling of the resin used the same procedure as for the cysteine amino acids.
Oxidation of Wild Type Peptide. During the synthesis of the wild type peptide Fmoc-Cys-S-Tmp
was used as the cysteine building block in both locations along the peptide. After the final
coupling but before the final deprotection and cleavage from the resin this peptide was oxidized.
To do this 0.1 M NMM (55 µL) in 5% dithiothreitol (DTT)/ 95% DMF was first added to the
resin and shaken for 5 min. (3X) to deprotect the STMP group42. The resin was then washed 4X
with DMF and 4X with DCM. The success of the deprotection was tested using a solution of
Ellman’s reagent and DCM on a sample of the resin beads. The resin was then washed 4X with
DMF. 2 eq. of N-chlorosuccinimide dissolved in 5 mL of DMF was then added to the resin and
shaken for 15 min. to for the disulfide bond. After washing 4X with DMF and then DCM the
resin was re-tested to confirm the oxidation. The final Fmoc group was then deprotected and the
peptide was cleaved from the resin. This process is illustrated in Figure 4.
Oxidation of the Homocysteine Peptides. Unlike the other peptides synthesized, the two
homocysteine containing peptides were oxidized post cleavage from the resin. CLEAR-OX™
resin was used to induce disulfide formation of the disulfide bond. This resin has 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB/ Ellman’s reagent) bound to a solid resin, was used to form the
disulfide bond. The CLEAR-OX™ resin was loaded at a 0.21 meq./g of resin ratio compared to
the peptide quantity, swelled in DCM for 40 min, then washed with DCM, DMF, methanol,
deionized water, and degassed 1:1 100 mM ammonium bicarbonate:acetonitrile 3 times each..
The solid peptides (2 and 3) were then dissolved in 1 mL/6 mg of 1:1 acetonitrile (ACN): 0.1 M
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ammonium bicarbonate (degassed). The solution was added to the resin and agitated for two
hours. Following agitation by shaking the solution was blown out of the vessel with N₂ gas,
diluted with water, and lyophilized. It was subsequently discovered that some DNTB and TNB
anion had detached from the resin and contaminated the sample. These impurities were removed
by binding the sample to DEAE-Sepharose resin (diethylaminoethanol). The impurities are
negatively charged at this pH, while the peptide is positively charged and unable to bind the
resin. The sample was dissolved in ammonia bicarbonate buffer, pH 7.5, and then added to a
small amount of resin that had been equilibrated with the same buffer. After agitating the sample
with the resin for 30 min, the resin slurry was transferred to a microcentrifuge tube fitted with a
filter. The eluent with the peptide was then collected by centrifugation and lyophilized. The
oxidation process is shown in Figure 5.
Oxidation of Selenocysteine Peptides. The oxidation of the Sec peptides occurs during their
cleavage from the resin. The xanthene protecting group was cleaved by the highly acidic
TFA:TIS:H₂O cleavage cocktail. The free oxygen in solution then allows the highly reactive
selenium to spontaneously oxidize with the cysteine residue forming the seleno-thiol bond. This
is illustrated in Figure 6.
Confirmation of Peptide Sequences. The purity, sequence, and oxidation of all synthesized
peptides were confirmed through mass spectral analysis using a Voyager-DETM PRO
Workstation (Applied Biosystems) based on calculated molecular weights for the peptides. These
are shown in Figures 15, 16, 17, 18, and 19.
Enzyme Assays. All assays were done using a spectrophotometer at A340. The parameters for all
assays were 500 µL total volume, 1 mM EDTA, 150 µM NADH, 100 mM KPO₄ buffer, 15 nM
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PfTRΔ7 truncated enzyme, and varying synthesized peptide concentrations. The assays
measured the consumption of NADH at A340, which was then used to calculate enzyme-peptide
activity using Beer’s Law.
Failed Oxidation of Peptides. Multiple copies of all synthesized peptides were made, but due to
the nature of the enzyme assay not all could be used due to the oxidative reagents utilized to
cyclize the disulfide or selenosulfide bond. Initially peptides I, II, and III of Table 1 were
oxidized using a molar equivalent of benzeneseleninic acid. This reagent was later determined to
give artificial activity to the enzyme assays. An extraction was attempted using 1:1 Phenol :
Chloroform, but not all of the contaminant was removed and some peptide was lost. Another
oxidation was done on peptide I only, after resynthesizing it, using DTNB in solution. This also
resulted in contamination and artificial activity, and again extraction using phenol-chloroform
was unsuccessful. Oxidation was then attempted again on resynthesized peptides II and III using
CLEAR-OX™ resin. This was also found to contaminate the samples with DTNB, so extraction
was done with DEAE-Sepharose resin as described above, and was successful. The alternate
Fmoc-Cys-S-Tmp synthesis described above was then used to oxidize peptide I on-resin, and
was successful.
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RESULTS AND DISCUSSION
Electrophilic Activation: Isolation of N-terminal to C-terminal thiol disulfide exchange
In nature Cys orthologs of Sec enzymes have been shown to possess mechanisms to
increase S-nucleophilicity that allow for increased rates of thiol disulfide exchange, to
compensate for the absence of the more nucleophilic selenium.29 Selenium is also a more
electrophilic atom than sulfur, and so it stands to reason that Cys orthologs of Sec enzymes in
which selenium acts as an electrophile have another mechanism to emulate this superior
electrophilicity.43 In mTR and other Sec TR enzymes selenium in the C-terminal redox center
acts as both an electrophile during N-terminal to C-terminal redox exchange and a nucleophile
during its attack on a substrate.28, 44 In order to catalyze the same reaction, TR enzymes that lack
Sec, such as DmTR and PfTR, must have mechanisms that change the properties of sulfur at
these steps to emulate the chemistry of selenium. Previous work investigating N-terminal to Cterminal disulfide exchange in DmTR provides evidence that the disulfide bond of the Cterminal redox center is polarized by an adjacent histidine residue, inducing a partial positive
charge on one of the sulfurs and priming it for attack by the N-terminal redox center. This
mechanism was termed “electrophilic activation”.30 Although the structures of the C-terminal
redox center differs between DmTR and PfTR I hypothesize that the two enzymes use a similar
mechanism of electrophilic activation to compensate for the absence of selenium in the
thiol/disulfide exchange step that occurs between the N- and C-terminal redox centers, as
illustrated in Figure 7.
To investigate this intramolecular mechanism I exploited the structure of PfTR to create
an intermolecular reaction instead. The C-terminal redox center of PfTR is conveniently located
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as the final eight amino acids of the enzyme’s sequence. It is also present on the exterior of the
protein, as it needs to interact with substrates. This allowed me to chemically synthesize
peptides, either of the wild type sequence or mutants, and assay them in a solution containing a
truncated variant of the enzyme (PfTRΔ7) which does not contain the C-terminal redox center.
The peptide binds to PfTRΔ7 as a substrate and is reduced by the N-terminal redox center as it
would be in the native enzyme, consuming NADPH in the process, as shown in Figure 10. By
creating mutant peptides that have had a cysteine replaced with either selenocysteine or
homocysteine I was then able to investigate the mechanism of this thiol disulfide exchange step.
The synthesized peptides are illustrated below in Table 1. This method of assaying a truncated
enzyme with a peptide as a substrate has also been used to investigate the C-terminal redox
center mechanism of DmTR and mTR. 21, 30
To provide an alternate method of analyzing the exchange mechanism, semisynthetic
enzymes of PfTR were also created. These were made by synthesizing mutant peptides with the
same sequences as peptides IV and V (sans the N-terminal glycine residue) and ligating them to
the truncated PfTRΔ7 enzyme using methods previously published by the Hondal lab.25 This
allowed me to determine the activity of these mutant redox centers on two natural substates of
PfTR; Trx and selenocystine. The results of these assays are shown in Table 2 and Figures 13
and 14.
Assessing the impact of Cys540Sec substitution
In mTR and other selenium containing TRs Sec is located at the more C-terminal position
within the redox center, and in DmTR the most C-terminal cysteine residue has been shown to
perform the same function that Sec does in mTR.45 Based on this it is hypothesized that the most
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C-terminal cysteine residue of the C-terminal redox center of PfTR, Cys540, takes on the role that
Sec plays in mTR. If this hypothesis is correct, then the sulfur atom of Cys540 is attacked during
thiol/disulfide exchange and then subsequently initiates nucleophilic attack onto the disulfide
bond of the substrate. To test this hypothesis, a mutant peptide (peptide IV in Table 1) with a
Cys540Sec substitution was synthesized. When assayed this peptide resulted in a significant
increase in PfTRΔ7 activity when compared to the WT (peptide I), as illustrated in Figure 11.
The effect of this substitution was also analyzed in a full length PfTR enzyme with its natural
substrates through semisynthesis. The semisynthetic analog of this mutant peptide, ligated
enzyme A, had Trx and selenocystine activity ~75 and ~25 fold higher than ligated enzyme B,
which has Cys535Sec substitution. The reason for this change in catalytic function is that by
replacing sulfur with the more electrophilic selenium the N-terminal redox center has a better
target for thiol disulfide exchange and the rate is consequently increased, as shown in Figure 9.
The rate increase at this substitution position provides evidence that Cys540 is indeed the residue
that is attacked during the intramolecular N-terminal to C-terminal redox exchange.
The question that then presents itself is that if Sec in this position does increase catalytic
function, why is it not included in the wild type enzyme? There are four selenoproteins coded for
by P. falciparum, so the organism has the correct “machinery” available to incorporate this
amino acid into proteins.46 A possible reason is that when a Cys540Sec substitution is
introduced the hydrogen peroxidase activity of PfTR goes up 6-fold, likely due to selenium’s
ability to not be irreversibly inactivated by oxidation as sulfur is.23, 25, 47 Its increased ability to
process hydrogen peroxidase could alter the redox balance of the cell and negatively affect some
processes of the organism. Another possible reason is that PfTR is specialized to reduce PfTrx,
hence its unique C-terminal structure. Although it lacks Sec, PfTR has similar activity reducing
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PfTrx to human TR reducing human Trx, while having very little activity on human Trx or those
of other species.48 The specialization of PfTR’s C-terminal redox center is important for
differentiation between PfTrx, its host’s human Trx, and its vector’s A. gambiae Trx, so if Sec
was introduced into this site it could negatively affect the enzyme’s ability to differentiate. The
PfTR C-terminal redox center could possibly be exploited as a potential anti-malarial drug target
due to this unique specialization, but further research would need to be done.
Assessing Cys535Sec substitution: The Seleno Effect
While the results of peptide 4 did confirm that Cys540 is the residue undergoing attack by the Nterminal redox center, it did nothing to prove the electrophilic activation hypothesis. To test this
hypothesis I synthesized peptide V, which has a Cys535Sec substitution. If we assume that it is
Cys540 that is undergoing attack, then the electrophilic activation hypothesis predicts that it must
be Cys535 that is interacting with an adjacent positive charge and polarizing the disulfide. If this
mechanism was not present in the enzyme then conventional chemical logic would assume that a
Cys535Sec substitution would result in an increase in catalytic activity, as selenium is a better
leaving group than sulfur due to its lower pKa.21 As illustrated in Figure 11 and Table 1 this is
not the case, with peptide V actually having a ~5-fold decrease in activity compared to the wild
type peptide. This leads to the assumption that not only is there an electrophilic activation
mechanism present in the wild type peptide that increases its activity, but also that selenium
substitution for sulfur inhibits this mechanism in some way. In the semisynthetic enzyme assays
ligated enzyme B had significantly lower activity than ligated enzyme A, which provides further
evidence for this inhibition. I hypothesize that this inhibition is due to a “seleno-effect” on the
hydrogen bonding between Cys535 and His509. Due to the differential effects seen in the two types
of selenium substitution, the data is consistent with an electrophilic activation mechanism in the
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reduction of the wild type peptide that increases its activity compared to not being activated due
to polarization of the disulfide. In the semisynthetic enzyme assays ligated enzyme B had
significantly lower activity than ligated enzyme A, which provides further evidence for the
proposed electrophilic activation mechanism.
The term “seleno-effect” is a derivative of the thio-effect, a phenomenon commonly
utilized in studying phosphodiesterases. In the thio-effect the substitution of sulfur in place of a
non-bridging oxygen within the DNA phosphate backbone disturbs hydrogen bonding between a
binding protein and the phosphate group and subsequently results in a measurable decrease in
activity.35 This disruption of hydrogen bonding is due to the lower pKa of sulfur compared to
oxygen, resulting in a less stable bond to a positively charged residue on the enzyme.34
The periodic column of chalcogens includes, in descending order, oxygen, sulfur, and
selenium (as well as tellurium and polonium which are not present in organisms). These
elements share common qualities, such as having six valence electrons, which leads to them
having a similar role within organic molecules. However, many qualities of these atoms change
as you go down the column, including increased size, decreased electronegativity, and decreased
pKas. The seleno-effect employs this change in basicity in the same way that the thio-effect
utilizes the difference in basicity between oxygen and sulfur, by disturbing a hydrogen bond that
would otherwise serve a role within the enzyme.
In the case of PfTR, it is the hydrogen bond that between Cys535 and His509 that will be
disturbed. By replacing Cys535 with Sec in peptide 5 the lower basicity of selenium will not allow
it to hydrogen bond as strongly to His509 as sulfur would. Following the electrophilic activation
hypothesis, it is this hydrogen bond that is polarizing the disulfide in the wild type and inducing
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a partial positive charge on Cys540, making it more electrophilic and prone to thiolate attack. So
by eliminating this bond the selenosulfide bond does not become polarized and Cys540 incurs no
positive charge, decreasing the rate of attack by the N-terminal redox center. This is shown in
Figure 8.
Assessing the importance of the C-terminal disulfide position
One of the features of the PfTR C-terminal redox center that I explored was the
importance of the position of the active disulfide in relation to the rest of the enzyme. To do this
I synthesized mutant peptides (II and III) with a homocysteine residue substituted for cysteine
and assayed them with the truncated enzyme (PfTRΔ7) to assess their activity. Homocysteine
substitution, which when compared to cysteine has an additional methylene unit (3 Å) between
the α-carbon and the thiol group, results in a peptide that forms a 21-membered ring when
oxidized. This seemingly minute change to the native 20-membered ring results in 3-fold loss of
activity when compared to the WT- peptide (I), as shown in Table 1 and Figure 12. Previous
research has shown that cysteinehomocysteine substitution in the C-terminal redox center of
semisynthetic PfTR enzymes results in a significant decrease in activity, and my research
supports these findings through the alternate method of peptide substrate assays.25 There are two
possible mechanisms for this decreased activity 1) this change in disulfide positioning affects the
rate of attack by the C-terminal thiolate on Trx or 2) the mutant peptide is an inferior substrate
for N-terminal attack and thiol disulfide exchange. As the N-terminalC-terminal redox
exchange is the rate limiting step of the enzyme the latter seems to be a more likely option. This
is consistent with the proposed electrophilic activation of the disulfide by His509. By substituting
homocysteine for cysteine the disulfide has a slightly altered location in the mutant peptide
relative to this His509 residue, which disturbs the hydrogen bonding between His509 and Cys535,
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thereby inhibiting electrophilic activation. This disruption of His509-Cys535 hydrogen bonding
will occur regardless of which cysteine residue is substituted with homocysteine, as the shift in
disulfide location will be roughly equal for substitution at either location. The results of the
assays reflect this, with very little difference in activity between the two homocysteine mutant
peptides (II and III).
Failed oxidations of peptides
The most difficult part of this research was not any of the processes involving assays or
peptide synthesis, but rather the oxidation of the synthesized peptides. In order to prepare the
peptides for assays they must be in the cyclized, oxidized form with either a disulfide or a
selenosulfide bond between the second and seventh residues. There are many common reagents
for this process, but the problem is than many of these same reagents are targets for TR. Even
when using PfTRΔ7 they can be reduced by the N-terminal redox center and give artificial
activity to the assay. Luckily, the Sec containing peptides (IV and V) will auto-oxidize after the
protecting group has been removed from the selenium residue, so there was no difficulty
oxidizing those two peptides. The first oxidizing reagent that I used was benzeneseleninic acid to
oxidize peptides I, II, and III. After we realized that the activities for all of these assays were far
too high we concluded that the oxidizing agent was contaminating the peptides and causing
artificial activity. Extraction of the benzeneseleninic acid from the peptides with phenolchloroform did not manage to completely remove the contaminant so I discarded those samples
and moved on. The next reagent that I tried was DTNB on peptide I only, which had the same
result as the diphenyl diselenide in that it gave artificial activity and was very difficult to extract.
This time I opted to extract the DTNB with HPLC, which did yield some fractions of pure
peptide sample. However, these fractions did not contain enough peptide to perform full assays
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and the sample was again discarded. After the DTNB failure I decided to oxidize my new
samples of peptides II and II with Clear-OxTM resin, which has DTNB bound to a solid resin and
hypothetically would allow me to remove the peptide after oxidation without any contamination.
This did not prove to be the case as the peptide solution was yellow after removal from the resin,
which is a telltale sign of TNB anion contamination. An extraction using HPLC was then
attempted, but as with the previous sample, the fractions containing the peptide were very dilute
and did not yield enough peptide after lyophilization to run a full assay. I then synthesized a
peptide I that would allow for on-resin oxidation, so that any oxidizing agents used could simply
be washed off of the peptide resin prior to cleavage. By utilizing Fmoc-Cys-S-Tmp instead of the
acid labile Fmoc-Cys-(Trt)OH I was able to remove the S-Tmp protecting group with the mild
reducing agent DTT, which does not cleave the peptide from the resin.42 I then treated resin with
N-Chlorosuccinimide to oxidize the cysteine residues and then washed it out with DMF and
DCM. The normal procedure was then followed to cleave the peptide from the resin. This
procedure worked well and no contaminants showed up in the assays or on mass spectrometry.
The only problem was that while oxidizing on resin worked well for peptide I, peptides II and III
contain homocysteine residues, which is not available as an Fmoc amino acid with an S-Tmp
protecting group. We decided to synthesize these peptides one final time and oxidize them as we
did before with the Clear-Ox resin. As expected, there was some TNB contamination following
the oxidation. To solve this problem we passed the peptide solution over a DEAE resin, an anion
exchange resin that binds the negatively charged TNB contaminants and lets the positively
charged peptides flow through. This was done multiple times until all of the peptide solution ran
clear and no characteristic TNB/DTNB peak at 412 nm was visible on the spectrophotometer.
The assays of peptides II and III were successful following this treatment.
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Conclusion.
I have investigated the C-terminal redox center of PfTR through peptide substrate assays
and semisynthesis. My results provide evidence that Cys540 is attacked by the N-terminal redox
center to initiate intramolecular thiol-disulfide exchange. This reaction is made favorable by an
electrophilic activation mechanism on the Cys535-Cys540 disulfide bond through hydrogen
bonding with His509, resulting in N-terminal attack on Cys540. The substitution of Cys535 with Sec
results in catalytic rate reduction, which I contend is evidence of a “seleno-effect” that inhibits
His509 hydrogen bonding and inhibits electrophilic activation. My results also demonstrate the
importance of the disulfide ring size on this catalytic mechanism as well as multiple methods for
oxidation of peptide disulfide bonds that prevent oxidant contamination.
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TABLES
Table 1: Activities of synthesized peptides assayed with PfTRΔ7
Peptide Peptide Sequence
#

Ring
size

Kcat (min1
)

Km
(mM)

Specific activity at 5
mM peptide (mol
NADPH/min/mol TR)
I
GC535GGGKC540G
20
320 ± 30
4.8 ± 0.9 167 ± 4
a
a
II
GCGGGKhCG
21
31 ± 3
III
GhCGGGKCG
21
155 ± 12
12 ± 1
47 ± 11
a
a
IV
GCGGGKUG
20
289 ± 36
V
GUGGGKCG
20
114 ± 32
12 ± 4.6 36 ± 18
a
These assays resulted in linear trends not suitable to plot with Michaelis-Menten

Table 2: Kinetics of semisynthetic enzymes with Trx and selenocystine

PfTR-CGGGKUG

Trx Kcat Trx KM (µM) Sec2 Kcat
(min-1)
(min-1)
561 ± 39 18 ± 5
672 ± 73

Sec2 KM
(µM)
84 ± 25

PfTR-UGGGKCG

7.3 ± 0.5 9.3 ± 3

68 ± 13

Ligated
Enzyme
A

Sequence

B

24 ± 1
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FIGURES

A

B

C

Figure 1: Thiol-disulfide exchange between Trx and a target protein. A) A reduced Trx cysteine
residue in the active site attacks the oxidized disulfide of a target protein. B) Formation of a
mixed disulfide transition state between Trx and its target. C) Exchange is complete; the target is
left reduced while Trx has formed an oxidized disulfide between its active site cysteine residues.
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Figure 2: Mammalian TR homodimer with redox centers shown. High MW TR enzymes
contain three redox centers in each monomer; a bound flavin domain, an N-terminal disulfide
redox center and a C-terminal disulfide redox center, as well as an NADPH binding domain.
Electrons flow through these redox centers to ultimately allow the C-terminal redox center to
reduce the substrate Trx. First, NADPH bind to its binding domain and reduces the flavin
domain. This flavin then reduces the disulfide of the N-teminal redox center. This redox center
then reduces the C-terminal redox center of the opposite monomer through thiol disulfide
exchange. In this depiction the right side of the enzyme is shown in the reduced configuration
while the left side is shown oxidized.
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Figure 3: General solid phase Fmoc peptide synthesis procedure. Solid phase peptide synthesis
is done on a resin that bind to the most C-terminal amino acid of the peptide. Each amino acid
is protected by an Fmoc group on its amino end. After the first amino acid is coupled to the
resin this Fmoc group is deprotected using piperidine. The next amino acid in the sequence (C->N) is then added to the resin with a coupling reagent and a peptide bond is formed. This cycle
of deprotection and coupling is repeated until the peptide sequence is complete. The peptide is
then cleaved from the resin using strong acid and precipitated.
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Figure 4: On resin oxidation of Peptide I. The cysteine residues of the peptide are protected
with Stmp. A cocktail of 0.1 M NMM in 1:20 DTT:DMF is used to cleave the Stmp groups.
Two molar equivalents of N-chlorosuccinamide is then used to form the disulfide between the
two cysteine residues. This method allows for disulfide formation to be done while the peptide
is still on the resin due to the lack of acid used in the protecting group cleavage.
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Figure 5: Off resin oxidation of homocysteine peptides (II and III). Cysteine and homocysteine
are both protected by an acid labile Trt group. Upon cleavage of the peptide from the resin
these groups were also removed. The peptides were then oxidized by passing them over a
ClearOxTM resin with bound DTNB oxidizing agent. This formed a disulfide within the peptide,
oxidizing it. Some TNB anions leaked off of the resin and contaminated the sample, so the
sample was then run through an anion exchange resin that removed the contaminating anions.
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Figure 6: Off resin oxidation of selenocystine peptides (IV and V). The cysteine residues were
protected by an acid labile Trt group, while the selenocysteine residue was protected by an acid
labile xanthene group. Upon cleavage of the peptide from the resin these groups were also
removed. Selenium then reacted with free oxygen in the solution to auto-oxidize the peptide,
forming a seleno-sulfide bond. Selenocysteine containing peptides were the easiest to oxidize
because they do not need any oxidizing reagent other than free oxygen in solution.
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PfTR-GC1GGGKC2G (WT)

Figure 7: Proposed PfTR C-terminal redox center electrophilic activation mechanism. Hydrogen
bonding between the positively charged His509 and the sulfur (S1) of Cys535 (C1) draws the
electrons of the disulfide bond toward S1, which then consequently induces a partial positive
charge in the sulfur (S2) of Cys540 (C2). This makes S2 more electrophilic and prone to attack by
the negatively charged attacking cysteine residue of the N-terminal redox center (CysIC).
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Figure 8: Mechanism of seleno effect rate reduction when Cys535 is substituted with Sec in Cterminal redox center of PfTR. When Cys535 is replaced with Sec the positive charge of His509
cannot induced a dipole within the selenosulfide bond. This is because selenium has a lower pKa
than sulfur and will not hydrogen bond as readily to the histidine residue. The sulfur (S2) of
Cys540 (C2) therefore no longer has an induced partial positive charge and is not a good
electrophile for the attacking N-terminal cysteine residue (CysIC). This reduces the rate of thioldisulfide exchange (kex) and the overall catalytic rate of PfTR.
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Figure 9: PfTR rate increase as a result of C-terminal redox center Cys540 to Sec substitution.
Cys540 is the proposed residue that undergoes attack to initiate thiol disulfide exchange between
the N-terminal and C-terminal redox centers. In this model Cys540 has been replaced by Sec.
Selenium is a much better nucleophile than sulfur, making it a better target of attack for the Nterminal cysteine (CysIC). This substitution consequently results in an increase in rate for PfTR.
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Figure 10: Redox cycle of full length PfTR with Trx as a substrate and PfTRΔ7 with a peptide
substrate. In order to isolate the exchange between the N-terminal and C-terminal redox centers
PfTRΔ7 was assayed with a peptide substrate with the structure of the C-terminal redox center.
This allowed the consumption of NADPH to directly reflect this redox exchange. In the full
length enzyme this exchange is intramolecular and Trx is the substrate being reduced.

Figure 11:	
  Enzyme assays of peptides 1, 4, and 5 with PfTRΔ7. This Michaelis-Menten plot
shows the Kcat of PfTRΔ7 with peptides 1, 4, and 5 as substrates plotted against peptide
concentration. These illustrate the difference in Sec substitution at the attacked Cys540, resulting
in an increase in activity, versus a Sec substitution at the activating Cys535, resulting in a decrease
due to the disturbance of electrophilic activation by the seleno-effect. These are plotted with the
wild type peptide to show relative activity.

	
  

Figure 12: Enzyme assays of peptides 1, 2, and 3 with PfTRΔ7. The Michaelis-Menten plot
shows the Kcat of PfTRΔ7 with peptides 1, 2, and 3 as substrates plotted against peptide
concentration. This shows the difference in activity between the wild type peptide and the two
homocysteine mutant peptides. Homocysteine substitution at either location results in a similar
reduction in PfTRΔ7 activity.
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Figure 13: Enzyme assay plot of ligated enzymes A and B with selenocystine as a substrate.
These Michealis-Menten curves show the how Sec for Cys substitution increases enzyme activity
towards selenocystine at Cys540 and decreases it at Cys535. This is due to the increased
electrophilicity of selenium over sulfur when acting as an electrophile at Cys540 and the
inhibition of PfTR’s electrophilic activation mechanism through the seleno effect at Cys535.
PfTR-GCGGGKUG has approximately 30 fold greater activity than PFTR-GUGGGKCG.
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Figure 14: Enzyme assay plot of ligated enzymes A and B with thioredoxin as a substrate. The
Michaelis-Menten curves show how enzyme activity following Cys540Sec substitution is much
greater than the activity following Cys535Sec substitution with Trx as a substrate. PfTRGCGGGKUG has approximately 75 fold greater activity than PfTR-GUGGGKCG.
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Figure 15: Mass spectral analysis of Peptide I. The molecular weight of Peptide I when oxidized is
636 (MW = 638 when reduced). The sample was analyzed through mass spectrometry using direct
infusion in positive ESI. The plot shows peaks at both the MW and one half of the MW (318) for the
doubly charged peptide.
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Figure 16: Mass spectral analysis of Peptide II. The molecular weight of Peptide II when oxidized is
650 (MW = 652 when reduced). The sample was analyzed through mass spectrometry using direct
infusion in positive ESI. The plot shows peaks at both the MW and one half of the MW (325) for the
doubly charged peptide.
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Figure 17: Mass spectral analysis of Peptide III. The molecular weight of Peptide III when oxidized
is 650 (MW = 652 when reduced). The sample was analyzed through mass spectrometry using direct
infusion in positive ESI. The plot shows peaks at both the MW and one half of the MW (325) for the
doubly charged peptide.
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Figure 18: Mass spectral analysis of Peptide IV. The molecular weight of Peptide IV when oxidized
is 684 (MW = 686 when reduced). The sample was analyzed through mass spectrometry using direct
infusion in positive ESI. The plot shows peaks at both the MW and one half of the MW (342) for the
doubly charged peptide.
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Figure 19: Mass spectral analysis of Peptide V. The molecular weight of Peptide V when oxidized is
684 (MW = 686 when reduced). The sample was analyzed through mass spectrometry using direct
infusion in positive ESI. The plot shows peaks at both the MW and one half of the MW (342) for the
doubly charged peptide.

	
  

